Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Try Now for Just $1!

INSM Company Profile and Key Details

NASDAQ : INSM

Insmed

$109.55
0.25+0.23%
At Close 4:00 PM
73.53
B+ESG ScoreESG Rating
ProfileKey StatsAnalyst RatingsOwnershipRatiosFinancialsDividend & splitsSentimentForecast

Price Chart

Stock Price Today

Insmed Incorporated (INSM) stock surged +0.23%, trading at $109.55 on NASDAQ, up from the previous close of $109.30. The stock opened at $108.69, fluctuating between $107.07 and $109.88 in the recent session.

Stock Snapshot

109.3
Prev. Close
23.16B
Market Cap
107.07
Day Low
-19.32
P/E Ratio
-5.67
EPS (TTM)
-3.79
Cash Flow per Share
108.69
Open
211.37M
Number of Shares
109.88
Day High
97.89%
Free Float in %
-2.29
Book Value
3.23M
Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing DateAccepted Date

Annual Report (10-k)

Filing DateAccepted Date

Stock Price History Chart

DateOpenHighLowCloseVolume
Aug 08, 2025108.69109.88107.07109.553.23M
Aug 07, 2025106.55111.94106.54109.303.33M
Aug 06, 2025110.22112.29109.61111.263.54M
Aug 05, 2025110.92113.10109.50111.613.21M
Aug 04, 2025109.25111.28108.00111.242.24M
Aug 01, 2025107.48108.89105.75108.692.26M
Jul 31, 2025105.58108.64105.18107.282.23M
Jul 30, 2025105.35107.41103.50105.185.13M
Jul 29, 2025102.68105.03102.21105.001.72M
Jul 28, 2025104.83105.80101.75101.752.68M
Jul 25, 2025103.93105.08103.20103.951.4M
Jul 24, 2025104.07104.95102.65103.521.59M
Jul 23, 2025102.92103.56101.55103.441.86M
Jul 22, 2025102.92103.74101.59102.921.53M
Jul 21, 2025103.34103.50101.77102.781.54M
Jul 18, 2025105.01105.01102.40102.561.43M
Jul 17, 2025104.73105.35102.50104.172M
Jul 16, 2025102.87105.08101.74104.593.69M
Jul 15, 2025102.67103.45100.85102.873.95M
Jul 14, 202598.18102.4197.34101.893.7M

Contact Details

Bridgewater, NJ 08807

United States

https://www.insmed.com908 977 9900

About Company

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey.

Company Information

Employees1271
Beta0.79
Sales or Revenue$305.21M
5Y Sales Change%15.981%
Fiscal Year EndsDecember
SectorHealthcare
IndustryMedical - Pharmaceuticals

Frequently Asked Questions

What is the current Insmed Incorporated (INSM) stock price?
Insmed Incorporated (NASDAQ: INSM) stock price is $109.55 in the last trading session. During the trading session, INSM stock reached the peak price of $109.88 while $107.07 was the lowest point it dropped to. The percentage change in INSM stock occurred in the recent session was 0.23% while the dollar amount for the price change in INSM stock was $0.25.
INSM's industry and sector of operation?
The NASDAQ listed INSM is part of Medical - Pharmaceuticals industry that operates in the broader Healthcare sector. Insmed Incorporated designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of INSM?
Eleanor Barisser
Associate Director of Investor Relations
Ms. S. Nicole Schaeffer
Chief People Strategy Officer
Mr. Roger Adsett
Chief Operating Officer
Dr. Martina Flammer M.B.A., M.D.
Chief Medical Officer
Ms. Sara M. Bonstein MBA
Chief Financial Officer
Mr. John Goll III
Senior Vice President & Chief Accounting Officer
Mandy Fahey
Executive Director of Corporation Communications
Mr. John Drayton Wise
Senior Vice President, Head of United States & Chief Commercial Officer
Mr. Michael Alexander Smith
Senior Vice President & Gen. Counsel
Mr. William H. Lewis J.D., M.B.A.
Pres, Chief Executive Officer & Chairman
Mr. Michael Alexander Smith J.D.
Senior Vice President, Gen. Counsel & Corporation Sec.
Ms. S. Nicole Schaeffer M.B.A.
Chief People Strategy Officer
Ms. Sara M. Bonstein M.B.A., MBA
Chief Financial Officer
Mr. Roger Adsett M.B.A.
Chief Operating Officer
Mr. John Drayton Wise M.B.A.
Chief Commercial Officer
Mr. Brian K. Kaspar Ph.D.
Chief Scientific Officer
How INSM did perform over past 52-week?
INSM's closing price is 81.37% higher than its 52-week low of $60.40 where as its distance from 52-week high of $113.10 is -3.14%.
How many employees does INSM have?
Number of INSM employees currently stands at 1,271.
Link for INSM official website?
Official Website of INSM is: https://www.insmed.com
How do I contact INSM?
INSM could be contacted at phone 908 977 9900 and can also be accessed through its website. INSM operates from 700 US Highway 202/206, Bridgewater, NJ 08807, United States.
How many shares of INSM are traded daily?
INSM stock volume for the day was 3.23M shares. The average number of INSM shares traded daily for last 3 months was 3.68M.
What is the market cap of INSM currently?
The market value of INSM currently stands at $23.16B with its latest stock price at $109.55 and 211.37M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

HomeAboutMeet The TeamContact UsPrivacy PolicyNewsletter

Useful Links

ScreenerMarket DataInsider TransactionsUpgrades & Downgrades52 Week Highs & LowsUnusual VolumeDividend CalendarEarnings CalendarStocks Watchlist
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph